Nuclide Therapeutics Revenue

Biotechnology Research • London, England, United Kingdom • 1-10 Employees

Nuclide Therapeutics revenue & valuation

Annual revenue	$342,220
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,100,000
Total funding	$6,700,000

Key Contact at Nuclide Therapeutics

Sofia Santos

Co-Founder

Company overview

Headquarters	124 City Road, London, England EC1V 2NX, GB
Websites	nuclidetx.com witneylab.com
NAICS	541714
Founded	2024
Employees	1-10

Nuclide Therapeutics Email Formats

Nuclide Therapeutics uses 1 email format. The most common is {first name} (e.g., john@nuclidetx.com), used 100% of the time.

Format	Example	Percentage
{first name}	john@nuclidetx.com	100%

About Nuclide Therapeutics

Giving refractory cancer patients an effective treatment option

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

Nuclide Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Explore Nuclide Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2025-10-22	3	$6,700,000

Funding Insights

$6,700,000

Total funding amount

$6,700,000

Most recent funding amount

Number of funding rounds

Nuclide Therapeutics Tech Stack

Discover the technologies and tools that power Nuclide Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Adobe Fonts

Font scripts

Modernizr

JavaScript libraries

Lodash

JavaScript libraries

reCAPTCHA

Security

Squarespace Commerce

Ecommerce

GoDaddy

Hosting

Open Graph

Miscellaneous

core-js

JavaScript libraries

YUI

JavaScript libraries

Squarespace

CMS

Google Font API

Font scripts

Microsoft 365

Frequently asked questions

Nuclide Therapeutics is located in London, England, GB.

Nuclide Therapeutics generates an estimated annual revenue of $342,220. This revenue figure reflects the company's market position and business performance in its industry.

Nuclide Therapeutics has an estimated valuation of $1,100,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Nuclide Therapeutics was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.

Nuclide Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Nuclide Therapeutics has raised a total of $6,700,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Nuclide Therapeutics

Sofia Santos

Co-Founder

4.8

40,000 users